Loading stock data…
EPC
$20.73+0.45 (+2.22%)
After Hours$20.37-0.36 (-1.74%)· Last close Jun 9
Edgewell Personal Care Company, together with its subsidiaries, manufactures and markets personal care products worldwide.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Edgewell Personal Care Company in the Consumer Defensive sector is trading at $20.73 with a market capitalization of $807M. Wall Street consensus targets $24.50 (6 analysts), implying a +18.2% move over the next 12 months. The stock is currently 24% below its 52-week high of $27.24, remaining 4.9% above its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 65/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply +18.2% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
Whystock Valuation Model
Anchored to each ticker's own 5-year median trailing P/E, tilted by current ROE and growth. Fair P/E = own median P/E + (ROE × 10) + (max(revenue growth, earnings growth) × 15), capped at ±30% around the historical anchor. Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. Premium compounders like COST/MSFT are judged against their own multi-year norm rather than a sector median. Falls back to the sector-anchored formula (Tech ≈ 28, Comm Services ≈ 24, Utilities ≈ 18, Financials ≈ 14, etc.) for recent IPOs and tickers with insufficient history (< 24 monthly samples). Result is a normalised multiple gauge — not a price target.
Current Price$20.73
Potential Downside
0%
Whystock Fair Value$20.73
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
Edgewell Personal Care Company, together with its subsidiaries, manufactures and markets personal care products worldwide. It operates through three segments: Wet Shave, Sun and Skin Care, and Feminine Care. The Wet Shave segment offers razor systems...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$807.34M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
0.56
Div Yield
Strong income play. Yield provides a meaningful total return floor.
2.89%
ROE
Average efficiency. Growth may require heavy reinvestment.
-2.07%
Volume
Today's trading volume
545,157
Recent News
3 Reasons to Sell EPC and 1 Stock to Buy Instead
Edgewell Personal Care currently trades at $17.82 per share and has shown little upside over the past six months, posting a middling return of 4.8%. The stock also fell short of the S&P 500’s 11% gain during that period.
3 Stocks Under $50 That Concern Us
The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to volatility as many lack the scale advantages of their larger peers.
3 Value Stocks That Fall Short
Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are usually cheap for a reason – five cents for a piece of fruit may seem like a great deal until you find out it’s rotten.
Edgewell Personal Care Q2 Earnings Call Highlights
Edgewell Personal Care (NYSE:EPC) reported fiscal second-quarter results that exceeded management’s expectations, with executives pointing to improving U.S. consumption trends, international market share gains and stronger execution across core categories following the divestiture of its Feminine Ca
Edgewell Personal Care (EPC) Q2 Earnings and Revenues Beat Estimates
Edgewell Personal (EPC) delivered earnings and revenue surprises of +39.54% and +0.63%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?